Zoekresultaten - 7 results
Humoral and cellular immune correlates of protection against COVID-19 in kidney transplant recipients.
Transplantation Prospective Studies SARS-CoV-2 Transplant Recipients Vaccination Abstract: As solid organ transplant recipients are at high risk of severe COVID-19 and respond poorly to primary SARS-CoV-2 mRNA ...
Invasive pulmonary aspergillosis in solid-organ transplant patients in the intensive care unit.
24, Issue 1 (2022) Keywords: Aspergillus Cohort Studies Humans intensive care units Invasive Pulmonary Aspergillosis Organ Transplantation Retrospective Studies Abstract: INTRODUCTION: Solid-organ ...
Seroprevalence of Antibodies against Diphtheria, Tetanus and Pertussis in Adult At-Risk Patients.
170), heart failure (= 77), HIV (= 196) and solid organ transplant (SOT) recipients (= 230). Factors associated with seroprevalence were analysed with multiple logistic regression. We found seroprotective ...
Treatment burden in patients with at least one class IV or V CFTR mutation
Conductance Regulator Drug Utilization Female Genotype Hospitalization Humans Infant Infant, Newborn Male Mutation Organ Transplantation REGISTRIES Respiratory Therapy Retrospective Studies Severity of Illness ...
A Simultaneous D-Optimal Designed Study for Population Pharmacokinetic Analyses of Mycophenolic Acid and Tacrolimus Early After Renal Transplantation86
agents used in combination with corticosteroids for the prevention of acute rejection after solid organ transplantation. Their pharmacokinetics (PK) show considerable unexplained intraindividual and ...
Validation of a liquid chromatography-mass spectrometric assay for tacrolimus in liver biopsies after hepatic transplantation: correlation with histopathologic staging of rejection.
Immunosuppressive Agents Liver Liver Transplantation Male middle aged Spectrometry, Mass, Electrospray Ionization Tacrolimus Tissue Distribution Abstract: The aims of this work were both to validate a sensitive and ...
Factors associated with clinical progression to severe COVID-19 in people with cystic fibrosis: A global observational study.
1555 people with CF, 1452 were included in the analysis. One third were aged <18 years, and 9.4% were solid-organ transplant recipients. 74.5% were symptomatic and 22% were admitted to hospital. In ...